The development of combination therapy involves several steps:
Preclinical Studies: Laboratory research is conducted to identify potential combinations that show synergistic effects. Clinical Trials: These are conducted in multiple phases to evaluate the safety and efficacy of the combination therapies in humans. Biomarker Identification: Identifying biomarkers can help predict which patients are most likely to benefit from the combination therapy. Regulatory Approval: Regulatory bodies review the clinical trial data to approve the combination therapy for clinical use.
